The anti-histamine drug ketotifen effectively induces apoptosis of NEPC tumor cells by targeting the interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) pathway, which reduces the survival rate of NEPC [68]. Here, IL6 is linked to neoplasm.